Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.81 |
| ▸ | DPP4 | P27487 | 1/20 | 0.72 |
| ▸ | CD38 | P28907 | 1/20 | 0.72 |
| ▸ | TYR | P14679 | 1/20 | 0.52 |
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.48 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.48 |
| ▸ | ALDH1B1 | P30837 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | IL2 | P60568 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | G6PD | P11413 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL673925 | 0.99 | F2 (0.83) | F2DPP4CD38TYRSLC28A3 | |
| SCHEMBL29378039 | 0.99 | F2 (0.83) | F2DPP4CD38TYRSLC28A3 | |
| Hydrochloric Acid SCHEMBL316939 | 0.93 | CD38 (0.83) | F2DPP4CD38TYRSLC28A3 | |
| Hydrochloric Acid SCHEMBL29991538 | 0.93 | CD38 (0.83) | F2DPP4CD38TYRSLC28A3 | |
| SCHEMBL29517863 | 0.92 | F2 (0.73) | F2DPP4CD38TYRSLC28A3 | |
| Hydrochloric Acid SCHEMBL3437710 | 0.92 | CD38 (0.82) | F2DPP4CD38TYRSLC28A3 | |
| SCHEMBL347415 | 0.92 | CD38 (0.85) | F2DPP4CD38TYRSLC28A3 | |
| SCHEMBL29380925 | 0.92 | CD38 (0.85) | F2DPP4CD38TYRSLC28A3 | |
| SCHEMBL29816518 | 0.92 | CD38 (0.85) | F2DPP4CD38TYRSLC28A3 | |
| SCHEMBL316940 | 0.92 | CD38 (0.85) | F2DPP4CD38TYRSLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 549 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117357544-A | Application of punicin in preparation of xanthine oxidase inhibitor | 青岛大学 | 2024-01-09 | — | — | CN | claimed |
| CN-115671286-B | Stereocomplex for delivery of anticancer agents | 田德扬 | 2023-12-08 | — | — | CN | claimed |
| CN-117074573-A | Method for discriminating fire baking degree of Wuyi cinnamon based on infrared and chromatographic methods of partial square method | 福建省农业科学院茶叶研究所 | 2023-11-17 | — | — | CN | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-20230355769-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2023-11-09 | — | — | US | claimed |
| US-20230338331-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2023-10-26 | — | — | US | claimed |
| US-20230313246-A1 | Application of Strain CH18 in Preparation of Anthocyanins and Other Flavonoid Compounds | BEIJING INSTITUTE OF TECHNOLOGY (CN) | 2023-10-05 | — | — | US | claimed |
| CN-115561966-B | Chemical amplification type negative photosensitive polyimide coating adhesive and application thereof | 明士(北京)新材料开发有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-114813985-A | Method for constructing HPLC fingerprint of capsule for treating arthralgia due to cold and heat | 长春英平药业有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114712508-A | Use of PDIA3 inhibitors in the prevention and treatment of CD4+ T cell dominated related diseases | 华中科技大学同济医学院附属同济医院 | 2022-07-08 | — | — | CN | claimed |
| CN-101312662-A | High-potency sweetener composition with antioxidant and compositions sweetened therewith | COCA COLA CO (US) | 2008-11-26 | — | — | CN | claimed |
| CN-100360115-C | Molecular coating method of plant polyphenol kind substance | XIE JUN (CN) | 2008-01-09 | — | — | CN | claimed |
| CN-1839903-A | Pharmaceutical composition containing glabrous sarcandra herb extract and its uses | JIANGXI BOSHILIAN SCIENCE AND (CN) | 2006-10-04 | — | — | CN | claimed |
| CN-1823730-A | Molecular coating method of plant polyphenol kind substance | XIE JUN (CN) | 2006-08-30 | — | — | CN | claimed |
| EP-1212376-B1 | SYNTHETIC VEGETAL MELANINS, PROCESS FOR THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEM | GHISALBERTI CARLO (BR) | 2006-02-01 | — | — | EP | claimed |
| EP-1212376-A1 | SYNTHETIC VEGETAL MELANINS, PROCESS FOR THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEREOF | Ghisalberti, Carlo (BR) | 2002-06-12 | — | — | EP | claimed |
| WO-2002002066-A1 | NAPHTHOMELANINS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS THEREOF | GHISALBERTI CARLO (BR) | 2002-01-10 | — | — | WO | claimed |
| WO-2001018125-A1 | SYNTHETIC VEGETAL MELANINS, PROCESS FOR THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEREOF | GHISALBERTI CARLO (BR) | 2001-03-15 | — | — | WO | claimed |
| EP-0496349-B1 | Coating solution for preventing adhesion of polymer scale and method for its use | SHINETSU CHEMICAL CO (JP) | 1996-04-10 | — | — | EP | claimed |
| EP-0496349-A1 | Coating solution for preventing adhesion of polymer scale and method for its use | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1992-07-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355769-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | CNR2, CNR1, UGT8 | ACHE 3117/4885F2 50/4885DPP4 4789/4885 |
| US-20230338331-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | CNR2, CNR1, UGT8 | ACHE 3117/4885F2 50/4885DPP4 4789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.